Revised timetable for prospectus release

CardieX Limited (ASX: $CDX) has provided a revised timetable for the Prospectus released to the ASX on 19 December 2023. The completion of the Placement is conditional on ASX agreeing to lift the Company's suspension from quotation. Completion of Tranche 2 of the Placement is also conditional on shareholder approval at the General Meeting. The above dates are indicative only and may change without notice.

Executive Commentary on Revised Timetable

The Company reserves the right to vary any and all of the above dates without notice, subject to the Corporations Act, Listing Rules and other applicable laws. In particular, the Company reserves the right to vary the opening date of any offer and the closing date of any offer without prior notice, which may have a consequential effect on the other dates. The Company also reserves the right not to proceed with the offers at any time before the issue of New Shares and Quoted Options. The Shortfall Offer may close at such earlier date as the Directors, in their absolute discretion, determine.

Summary of Revised Timetable for Prospectus

CardieX Limited (ASX: $CDX) has provided a revised timetable for the Prospectus release, indicating that the completion of the Placement is conditional on ASX agreeing to lift the Company's suspension from quotation. Completion of Tranche 2 of the Placement is also conditional on shareholder approval at the General Meeting. The Company reserves the right to vary the dates without notice, subject to relevant laws. Forward-looking statements in the announcement caution readers not to place undue reliance on the provided information and indicate that actual results may differ materially from the expressed or implied statements.